Outset Medical, Inc. (OM) intrinsic value & 10-year financials
Outset Medical, Inc. (OM) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 9 fiscal years revenue grew 79.3% a year to $119.5M, with an average return on invested capital of -29.3%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $3.94
- Market cap
- $59.9K
- Revenue (FY2025)
- $119.5M
- Revenue growth (9-yr CAGR)
- 79.3%
- ROIC (10-yr avg)
- -29.3%
- Free cash flow (FY2025)
- -$47.1M
OM 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $119.5M | -$81.7M | -$5.37 | -$47.1M | -55.8% | -45.3% |
| FY2024 | $113.7M | -$128.0M | -$2.46 | -$117.2M | -99.7% | -77.7% |
| FY2023 | $130.4M | -$172.8M | -$3.48 | -$134.8M | -130.2% | -73.2% |
| FY2022 | $115.4M | -$163.0M | -$3.38 | -$154.1M | -139.6% | -64.0% |
| FY2021 | $102.6M | -$131.9M | -$2.89 | -$133.4M | -127.2% | -87.1% |
| FY2020 | $49.9M | -$121.5M | -$4.85 | -$108.1M | -235.2% | 76.1% |
| FY2019 | $15.1M | -$68.3M | — | -$73.6M | -466.3% | 18.5% |
| FY2018 | $2.0M | -$49.8M | — | -$48.2M | -2320.0% | 18.5% |
| FY2017 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Outset Medical, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Outset Medical, Inc. has historically struggled to out-earn its cost of capital, averaging just -29.3% ROIC.
Outset Medical, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Outset Medical, Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-178.37 per share.